PostEra spearheads $68M collaboration to develop antivirals funded by the NIH

May 19, 2022

About PostEra

PostEra is building a modern 21st century biopharma.

We use our advances in machine learning to accelerate medicinal chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We’ve raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and helped lead the world's largest open-science drug discovery effort; COVID Moonshot.